By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


CytRx Corporation 

11726 San Vicente Blvd., Suite 650

Los Angeles  California  90049  U.S.A.
Phone: 310-826-5648 Fax: 310-826-6139


Company News
CytRx Corporation (CYTR) Initiates Phase 1b Clinical Trial With Combination Of Aldoxorubicin And Ifosfamide/Mesna As First-Line Treatment In Patients With Advanced Sarcomas 9/9/2014 10:58:14 AM
CytRx Corporation (CYTR) Updates Presentation Time At Aegis 2014 Healthcare & Technology Conference 9/5/2014 11:08:57 AM
CytRx Corporation (CYTR) To Present At Upcoming Investor Conferences In New York City And Las Vegas 9/2/2014 1:51:08 PM
Oral Presentation Of CytRx Corporation (CYTR)’s Aldoxorubicin Phase 2b Clinical Trial In Soft Tissue Sarcoma Highlighted In The Lancet Oncology 8/7/2014 10:06:35 AM
CytRx Corporation (CYTR) Reports 2014 Second Quarter Financial Results 8/6/2014 9:21:07 AM
CytRx Corporation (CYTR) Added To Russell 3000® And Russell 2000® Indexes 6/30/2014 11:27:39 AM
CytRx Corporation (CYTR) To Present At The Jefferies and Co. 2014 Global Healthcare Conference 5/29/2014 7:30:04 AM
CytRx Corporation (CYTR) Highlights Aldoxorubicin Data From Its Global Phase 2b Clinical Trial In First-Line Soft Tissue Sarcoma 5/28/2014 9:08:59 AM
CytRx Corporation (CYTR) Reports Completed Phase 1b/2 Progression-Free Survival And Overall Survival Aldoxorubicin Data In Second-Line Soft Tissue Sarcoma 5/5/2014 9:00:37 AM
CytRx Corporation (CYTR) Reports 2014 First Quarter Financial Results 5/1/2014 2:47:19 PM